Skip to main content
$26.65 +0.01 (+0.04%) At close · Jul 29

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$26.65 Open$26.71 Day$26.62–26.74 52W$26.22–29.05 Avg vol 30d24K Short int18K · 1.2d Short vol80% DataJan 2020–Jul 2026 Filing10-Q · Jul 8

Up next

FQ4-26 quarter ends
~Aug 31, 2026 Est
filed Jul 8, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Weak Sentiment Bullish Fundamentals Poor Quant / Vol Very Low
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −4%
below
Price vs 50-day avg −2%
below
RSI (14) 39
neutral
MACD trend Positive
52-week position 15%
mid-range
Momentum
relative strength
Very Weak
1-month return 0%
trailing
6-month return −4%
trailing
YTD return −2%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Accumulating
2 of 2 funds reported for Jun 30 · net +13 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -63.6% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
2 holders — near 4-yr low, contrarian setup
Fundamentals
Poor
Revenue growth −10%
Y/Y
Gross margin 3%
contracting
Free cash flow $-92.8M
Balance sheet $1.5B
net debt
Quant / Vol
risk profile
Very Low
Volatility 10%
annualized · 1-yr
Max drawdown −9%
past year
ATR 0.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−4% Neutral
Price vs 50-day avg
−2% Neutral
RSI (14)
39 Neutral
MACD trend
Positive Bullish
52-week position
15% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $27 › 200d $28 — 200d above 50d
Institutional flow Accumulating
2 of 2 funds reported for Jun 30 · net +13 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
▼ -63.6% MoM · 1.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
2 holders — near 4-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $26 Now $27 · 15% 52-wk high $29
vs 200-day avg -4% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Farm Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CHSCP
Chs Inc
this stock
-2.1% -9.7%
ADM
Archer-Daniels-Midland Co
$40.09B +40.9% -6.2% 37.1 3.5%
BG
Bunge Global SA
$22.77B +21.7% +32.4% 27.4 3.2%
TSN
Tyson Foods, Inc.
$21.54B +5.0% +2.1% 48.2 2.7%
CALM
Cal-Maine Foods Inc
$4.39B +18.5% -31.7% 14.1 12.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
2
Reported
2 of 2
Top holder
HUNTINGTON NATIONAL BANK
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Falling
Shares short
17.7K
Days to cover
1.2d
Change
-31.0K sh
View
Short Volume
Short vol %
80%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
853
Value
$23.7K
As of
Jun 12, 2026
View
Off-Exchange
Off-exchange %
65.2%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$35.5B
Net income (FY)
$597.9M
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 8, 2026
This year
10
View

Performance

5D 20D 120D MTD YTD
CHSCP +0.0% -0.2% -4.3% -0.2% -2.1%
SPY -2.4% -2.3% +6.3% -2.3% +7.0%
vs SPY +2.4% +2.1% -10.6% +2.1% -9.0%

Capital returns

Latest dividend
$0.50 / share · ex Jun 15, 2026
Paid (TTM)
$2.00 / share · 4 payouts
Dividend yield (TTM, derived)
7.50%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 823277 CUSIP 12542R209 13F (30d) 1 filings 1 filers Visit website